Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral May/19/2021 26 7
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Convalescent plasma Emergency use authorization Experimental Antiviral Apr/10/2021 37 6
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Feb/12/2021 26 13
Acetylsalicylic acid Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/10/2020 2 0
(1,3-Dimethylpyrazol-4-yl)-[4-(4-fluorophenyl)piperazin-1-yl]methanone Potential treatment - theoretical effect Experimental Antiviral Oct/23/2020 1 0
Ac-QS5-VS Potential treatment - pre-clinical evidence Experimental Antiviral Oct/22/2020 1 0
ACE2 receptor trap Potential treatment - pre-clinical evidence Experimental Antiviral Oct/22/2020 1 0
Almitrine Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/21/2020 3 0
Naringenin Potential treatment - pre-clinical evidence Natural product Antiviral Oct/20/2020 1 0